176 related articles for article (PubMed ID: 24037998)
1. Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension.
Surie S; Reesink HJ; Marcus JT; van der Plas MN; Kloek JJ; Vonk-Noordegraaf A; Bresser P
Clin Cardiol; 2013 Nov; 36(11):698-703. PubMed ID: 24037998
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of improvement in exercise capacity after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: correlation with echocardiographic parameters.
Kepez A; Sunbul M; Kivrak T; Eroglu E; Ozben B; Yildizeli B; Mutlu B
Thorac Cardiovasc Surg; 2014 Feb; 62(1):60-5. PubMed ID: 23564536
[TBL] [Abstract][Full Text] [Related]
3. Exercise facilitates early recognition of cardiac and vascular remodeling in chronic thromboembolic pulmonary hypertension in swine.
Stam K; van Duin RWB; Uitterdijk A; Cai Z; Duncker DJ; Merkus D
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H627-H642. PubMed ID: 29167118
[TBL] [Abstract][Full Text] [Related]
4. Changes in right ventricular structure and function assessed using cardiac magnetic resonance imaging in bosentan-treated patients with pulmonary arterial hypertension.
Chin KM; Kingman M; de Lemos JA; Warner JJ; Reimold S; Peshock R; Torres F
Am J Cardiol; 2008 Jun; 101(11):1669-72. PubMed ID: 18489949
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy.
Claessen G; La Gerche A; Dymarkowski S; Claus P; Delcroix M; Heidbuchel H
J Am Heart Assoc; 2015 Mar; 4(3):e001602. PubMed ID: 25801760
[TBL] [Abstract][Full Text] [Related]
6. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary endarterectomy normalizes interventricular dyssynchrony and right ventricular systolic wall stress.
Mauritz GJ; Vonk-Noordegraaf A; Kind T; Surie S; Kloek JJ; Bresser P; Saouti N; Bosboom J; Westerhof N; Marcus JT
J Cardiovasc Magn Reson; 2012 Jan; 14(1):5. PubMed ID: 22240072
[TBL] [Abstract][Full Text] [Related]
8. Balloon pulmonary angioplasty improves interventricular dyssynchrony in patients with inoperable chronic thromboembolic pulmonary hypertension: a cardiac MR imaging study.
Yamasaki Y; Nagao M; Abe K; Hosokawa K; Kawanami S; Kamitani T; Yamanouchi T; Horimoto K; Yabuuchi H; Honda H
Int J Cardiovasc Imaging; 2017 Feb; 33(2):229-239. PubMed ID: 27672065
[TBL] [Abstract][Full Text] [Related]
9. Functional and metabolic recovery of the right ventricle during Bosentan therapy in idiopathic pulmonary arterial hypertension.
Spindler M; Schmidt M; Geier O; Sandstede J; Hahn D; Ertl G; Beer M
J Cardiovasc Magn Reson; 2005; 7(5):853-4. PubMed ID: 16353449
[TBL] [Abstract][Full Text] [Related]
10. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension.
Galiè N; Hinderliter AL; Torbicki A; Fourme T; Simonneau G; Pulido T; Espinola-Zavaleta N; Rocchi G; Manes A; Frantz R; Kurzyna M; Nagueh SF; Barst R; Channick R; Dujardin K; Kronenberg A; Leconte I; Rainisio M; Rubin L
J Am Coll Cardiol; 2003 Apr; 41(8):1380-6. PubMed ID: 12706935
[TBL] [Abstract][Full Text] [Related]
11. Right ventricular dysfunction in chronic thromboembolic obstruction of the pulmonary artery: a pressure-volume study using the conductance catheter.
McCabe C; White PA; Hoole SP; Axell RG; Priest AN; Gopalan D; Taboada D; MacKenzie Ross R; Morrell NW; Shapiro LM; Pepke-Zaba J
J Appl Physiol (1985); 2014 Feb; 116(4):355-63. PubMed ID: 24356516
[TBL] [Abstract][Full Text] [Related]
12. Right ventricular adaptation to pulmonary pressure load in patients with chronic thromboembolic pulmonary hypertension before and after successful pulmonary endarterectomy--a cardiovascular magnetic resonance study.
Rolf A; Rixe J; Kim WK; Börgel J; Möllmann H; Nef HM; Liebetrau C; Kramm T; Guth S; Krombach GA; Mayer E; Hamm CW
J Cardiovasc Magn Reson; 2014 Dec; 16(1):96. PubMed ID: 25475583
[TBL] [Abstract][Full Text] [Related]
13. Right ventricular relative wall thickness as a predictor of outcomes and of right ventricular reverse remodeling for patients with pulmonary hypertension.
Sano H; Tanaka H; Motoji Y; Fukuda Y; Mochizuki Y; Hatani Y; Matsuzoe H; Hatazawa K; Shimoura H; Ooka J; Ryo-Koriyama K; Nakayama K; Matsumoto K; Emoto N; Hirata KI
Int J Cardiovasc Imaging; 2017 Mar; 33(3):313-321. PubMed ID: 27783186
[TBL] [Abstract][Full Text] [Related]
14. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension.
Reesink HJ; Tulevski II; Marcus JT; Boomsma F; Kloek JJ; Vonk Noordegraaf A; Bresser P
Ann Thorac Surg; 2007 Aug; 84(2):537-43. PubMed ID: 17643631
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension.
Iglarz M; Landskroner K; Bauer Y; Vercauteren M; Rey M; Renault B; Studer R; Vezzali E; Freti D; Hadana H; Schläpfer M; Cattaneo C; Bortolamiol C; Weber E; Whitby BR; Delahaye S; Wanner D; Steiner P; Nayler O; Hess P; Clozel M
J Cardiovasc Pharmacol; 2015 Nov; 66(5):457-67. PubMed ID: 26230396
[TBL] [Abstract][Full Text] [Related]
16. A comparison of echocardiographic variables of right ventricular function with exercise capacity after bosentan treatment in patients with pulmonary arterial hypertension: Results from a multicenter, prospective, cohort study.
Kim H; Bae Lee J; Park JH; Yoo BS; Son JW; Yang DH; Lee BR
J Clin Ultrasound; 2017 Jan; 45(1):28-34. PubMed ID: 27619758
[TBL] [Abstract][Full Text] [Related]
17. Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle.
Reesink HJ; Marcus JT; Tulevski II; Jamieson S; Kloek JJ; Vonk Noordegraaf A; Bresser P
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):58-64. PubMed ID: 17198781
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension.
Fenster BE; Lasalvia L; Schroeder JD; Smyser J; Silveira LJ; Buckner JK; Brown KK
Heart Vessels; 2016 Jun; 31(6):939-46. PubMed ID: 25976729
[TBL] [Abstract][Full Text] [Related]
19. Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A systemic review and meta-analysis.
Chen X; Zhai Z; Huang K; Xie W; Wan J; Wang C
Clin Respir J; 2018 Jun; 12(6):2065-2074. PubMed ID: 29393580
[TBL] [Abstract][Full Text] [Related]
20. Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study.
Peacock AJ; Crawley S; McLure L; Blyth KG; Vizza CD; Poscia R; Francone M; Iacucci I; Olschewski H; Kovacs G; Vonk Noordegraaf A; Marcus JT; van de Veerdonk MC; Oosterveer FP
Circ Cardiovasc Imaging; 2014 Jan; 7(1):107-14. PubMed ID: 24173272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
